Life sciences company Avantor (NYSE:AVTR) reported Q1 CY2026 results beating Wall Street’s revenue expectations, but sales ...
StockStory.org on MSN
AVTR Q1 deep dive: Leadership changes, segment stabilization, and execution drive outlook
Life sciences company Avantor (NYSE:AVTR) announced in Q1 CY2026, but sales were flat year on year at $1.58 billion. Its ...
Investors in Avantor Inc (Symbol: AVTR) saw new options become available this week, for the February 2025 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, ...
StockStory.org on MSN
Avantor (AVTR) Q1 earnings: What to expect
Life sciences company Avantor (NYSE:AVTR) will be reporting earnings this Wednesday before market hours. Here’s what to expect. Avantor beat analysts’ revenue expectations last quarter, reporting ...
Avantor, Inc. AVTR is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The optimism led by solid fourth-quarter 2024 results and strategic deals also looks ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Avantor, Inc. (NYSE:AVTR) is one of the 10 Best Medical Stocks to Buy Under $30. On April 1, William Blair reaffirmed its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results